Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
It’s important to discuss any side effects you may have with your health care provider.
Isentress (raltegravir), the first integrase inhibitor on the market for both treatment-naive and treatment-experienced patients, caused centr...
The integrase inhibitor Isentress may be associated with central nervous system symptoms, particularly when used with tenofovir or a pro...
Starting efavirenz (found in Sustiva and Atripla) at a lower dose and steadily increasing it over two weeks might help decrease the risk or se...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.